Pharmaceutical ETFs on the Rise

Celgene (

CELG

) announced it was buying Abraxis (

ABII

), and Sanofi-Aventis (

SNY

) said it would buy privately held TargeGen. Additionally, AstraZeneca (

AZN

) won a patent ruling over its drug Crestor. Turning to Pharma ETFs, the Pharmaceutical HOLDRS ETF (

PPH

) is trading about flat, while the Biotech HOLDRS (

BBH

) is trading higher by almost two tenths of a percent. The SPDR S&P Pharmaceuticals ETF (

XPH

) is trading higher by nearly half a percent Wednesday. According to

ETFChannel.com

Pharmceutical HOLDRS ETF

has about 25% of their holdings in Johnson & Johnson (

JNJ

), followed by Merck & Co (

) and Pzifer (

has Amgen (

) as their largest holding, followed by Gilead Sciences (

GILD

). The

SPDR S&P Pharmaceuticals ETF

has Valeant Pharma (

VRX

) as their largest holding, followed by Salix Pharma (

SLXP

). Learn how to find the best

stocks to trade each day in our 70 page E-Book and 90 minute online video

for free.

Market News and Data brought to you by Benzinga APIs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments